Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches

In recent years, the use of immune checkpoint inhibitors (ICIs) in combination with approved or experimental vaccines has proven to be a promising approach to improve vaccine immunogenicity and efficacy. This strategy seeks to overcome the immunosuppressive mechanisms associated with the vaccine res...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista-Duharte, Alexander, Hassouneh, Fakhri, Alvarez-Heredia, Pablo, Pera, Alejandra, Solana, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415890/
https://www.ncbi.nlm.nih.gov/pubmed/36015348
http://dx.doi.org/10.3390/pharmaceutics14081721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415890/
https://www.ncbi.nlm.nih.gov/pubmed/36015348
http://dx.doi.org/10.3390/pharmaceutics14081721

Ejemplares similares